The Edelman Laboratory, located at the Harvard-MIT Division of Health
Science and Technology (HST), integrates the fields of vascular biology tissue engineering and biomedical engineering. The laboratory uses elements of continuum mechanics, digital signal processing, molecular biology and
polymeric controlled release technology to examine the cellular and
molecular mechanisms that transform stable coronary-artery disease to
unstable coronary syndromes.
The Artzi laboratory, located at Brigham and [UTF-8?]Women’s Hospital-
Harvard Medical School, uses materials science and nanotechnology to design smart biomaterials for medical applications while integrating cutting edge imaging techniques to examine tissue:biomaterial interactions and material performance and healing capacity. Publications are available at:
http://web.mit.edu/hst-
*Position description:*
The position is within the framework of a sponsored program aiming to develop a new regenerative medicine / cancer immunotherapy technology using polymer-nanoparticle composite hydrogels designed for local endogenous immune modulation. The project will cover aspects of biomaterials, drug delivery, cell and vascular biology, monocyte/dendritic cell activation, antigen presentation and animal studies.
*Qualifications:*
*
*Candidates should have a Ph.D. and/or M.D. in cancer immunotherapy, immunology, biotechnology, biochemistry or a related field, with personal interest in translational applicable research. Candidate must have multi-disciplinary hands-on experience in cell biology and small animal models of cancer. The ability to be independent while also working in a team environment is crucial. The candidate should also have exceptional written and verbal communication skills, be self-motivated and have demonstrated productivity.
Interested candidates should send their C.V. and list of references to Prof. Natalie Artzi; nartzi@mit.edu and to Prof. Juliana Dreyfuss jdreyfuss@unifesp.br
The Artzi laboratory, located at Brigham and [UTF-8?]Women’s Hospital-
Harvard Medical School, uses materials science and nanotechnology to design smart biomaterials for medical applications while integrating cutting edge imaging techniques to examine tissue:biomaterial interactions and material performance and healing capacity. Publications are available at:
http://web.mit.edu/hst-
*Position description:*
The position is within the framework of a sponsored program aiming to develop a new regenerative medicine / cancer immunotherapy technology using polymer-nanoparticle composite hydrogels designed for local endogenous immune modulation. The project will cover aspects of biomaterials, drug delivery, cell and vascular biology, monocyte/dendritic cell activation, antigen presentation and animal studies.
*Qualifications:*
*
*Candidates should have a Ph.D. and/or M.D. in cancer immunotherapy, immunology, biotechnology, biochemistry or a related field, with personal interest in translational applicable research. Candidate must have multi-disciplinary hands-on experience in cell biology and small animal models of cancer. The ability to be independent while also working in a team environment is crucial. The candidate should also have exceptional written and verbal communication skills, be self-motivated and have demonstrated productivity.
Interested candidates should send their C.V. and list of references to Prof. Natalie Artzi; nartzi@mit.edu and to Prof. Juliana Dreyfuss jdreyfuss@unifesp.br
0 comentários:
Postar um comentário